These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 14601553)

  • 1. Optimizing efficacy and tolerability in today's HAART.
    Pozniak A
    AIDS Read; 2003 Sep; ():S4-8. PubMed ID: 14601553
    [No Abstract]   [Full Text] [Related]  

  • 2. Enhancing adherence to antiretrovirals: strategies and regimens.
    Stone VE
    MedGenMed; 2002 Jul; 4(3):22. PubMed ID: 12466765
    [No Abstract]   [Full Text] [Related]  

  • 3. HIV therapeutics in children and adults and their side effects.
    Laurence J
    AIDS Read; 2004 Jan; 14(1):6-7. PubMed ID: 14959697
    [No Abstract]   [Full Text] [Related]  

  • 4. Take HAART: medication adherence in the era of highly active antiretroviral therapy.
    Allardice K
    Aust Nurs J; 2002 Apr; 9(9):19-21. PubMed ID: 12017049
    [No Abstract]   [Full Text] [Related]  

  • 5. Effectiveness and tolerability of a once-daily amprenavir/ritonavir-containing highly active antiretroviral therapy regimen in antiretroviral-naïve patients at risk for nonadherence: 48-week results after 24 weeks of directly observed therapy.
    Jayaweera DT; Kolber MA; Brill M; Tanner T; Campo R; Rodriguez A; Chu HM; Garg V
    HIV Med; 2004 Sep; 5(5):364-70. PubMed ID: 15369512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SP-01A helps with quality of life.
    AIDS Patient Care STDS; 2008 Feb; 22(2):160-1. PubMed ID: 18273942
    [No Abstract]   [Full Text] [Related]  

  • 7. [Focus on the HIV patient: from simple therapy regimen to long-term success].
    MMW Fortschr Med; 2002 Aug; 144(31-32):46-7. PubMed ID: 12422732
    [No Abstract]   [Full Text] [Related]  

  • 8. Psychosocial determinants of adherence to highly active antiretroviral therapy among injection drug users in Vancouver.
    Kerr T; Palepu A; Barness G; Walsh J; Hogg R; Montaner J; Tyndall M; Wood E
    Antivir Ther; 2004 Jun; 9(3):407-14. PubMed ID: 15259903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Quality of life as the focus of modern anti-HIV treatment. More compact regimens for therapy success].
    MMW Fortschr Med; 2001 Sep; 143(35-36):58-9. PubMed ID: 11584536
    [No Abstract]   [Full Text] [Related]  

  • 10. [Which antiretroviral strategy to use in adults?].
    Tonnerre P
    Rev Infirm; 2003 Sep; (93):12-6. PubMed ID: 14593983
    [No Abstract]   [Full Text] [Related]  

  • 11. Modified directly observed therapy for the treatment of HIV-seropositive substance users: lessons learned from a pilot study.
    Macalino GE; Mitty JA; Bazerman LB; Singh K; McKenzie M; Flanigan T
    Clin Infect Dis; 2004 Jun; 38 Suppl 5():S393-7. PubMed ID: 15156428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of short-term success of antiretroviral therapy in HIV infection.
    Oette M; Kroidl A; Göbels K; Stabbert A; Menge M; Sagir A; Kuschak D; O'hanley T; Bode JG; Häussinger D
    J Antimicrob Chemother; 2006 Jul; 58(1):147-53. PubMed ID: 16687458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rational use of antiretroviral therapy in low-income and middle-income countries: optimizing regimen sequencing and switching.
    Elliott JH; Lynen L; Calmy A; De Luca A; Shafer RW; Zolfo M; Clotet B; Huffam S; Boucher CA; Cooper DA; Schapiro JM
    AIDS; 2008 Oct; 22(16):2053-67. PubMed ID: 18753937
    [No Abstract]   [Full Text] [Related]  

  • 14. Challenges of adherence management in human immunodeficiency virus pharmacotherapy.
    Park-Wyllie LY; Phillips EJ
    Can J Clin Pharmacol; 2003; 10(4):189-95. PubMed ID: 14712324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hospital-based directly observed therapy for HIV-infected children and adolescents to assess adherence to antiretroviral medications.
    Glikman D; Walsh L; Valkenburg J; Mangat PD; Marcinak JF
    Pediatrics; 2007 May; 119(5):e1142-8. PubMed ID: 17452493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Approaches to interrupting HAART for the treatment of HIV infection. IAPAC sessions 2001, July 18-19, 2001 - Chicago.
    Dybul M;
    IAPAC Mon; 2001 Aug; 7(8):232-4. PubMed ID: 11708275
    [No Abstract]   [Full Text] [Related]  

  • 17. Prolongation and quality of life for HIV-infected adults treated with highly active antiretroviral therapy (HAART): a balancing act.
    Burgoyne RW; Tan DH
    J Antimicrob Chemother; 2008 Mar; 61(3):469-73. PubMed ID: 18174196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiretroviral therapy interruption guided by CD4 cell counts and plasma HIV-1 RNA levels in chronically HIV-1-infected patients.
    Ruiz L; Paredes R; Gómez G; Romeu J; Domingo P; Pérez-Alvarez N; Tambussi G; Llibre JM; Martínez-Picado J; Vidal F; Fumaz CR; Clotet B;
    AIDS; 2007 Jan; 21(2):169-78. PubMed ID: 17197807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment interruption in HIV therapy: a SMART strategy?
    Jülg B; Goebel FD
    Infection; 2006 Jun; 34(3):186-8. PubMed ID: 16804667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Lack of compliance means no success].
    Kuhlmann B
    MMW Fortschr Med; 2005 Apr; 147 Spec No 1():18-9. PubMed ID: 16385864
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.